Sildenafil Recovers Burn-Induced Cardiomyopathy

Area of Science:

• Cardiovascular Science
• Pharmacology
• Burn Injury Research

Background:

• Severe burn injury triggers a detrimental cycle of inflammation, fibrosis, oxidative stress, and cardiac mitochondrial damage.
• The phosphodiesterase type 5 A (PDE5A)-cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) pathway is implicated in this process.

Purpose of the Study:

• To investigate the role of the PDE5A-cGMP-PKG pathway in burn-induced heart dysfunction.
• To evaluate the therapeutic potential of sildenafil in mitigating cardiac damage following severe burns.

Main Methods:

• Utilized a rat model of severe scald burn (60% total body surface area).
• Groups included sham, sham/sildenafil, burn, and burn/sildenafil.
• Assessed cardiac function, oxidative stress markers, inflammation, fibrosis, and gene expression.

Main Results:

• Sildenafil modulated the PDE5A-cGMP-PKG pathway, normalizing gene expression and reducing reactive oxygen species (ROS) and oxidative adducts (MDA, carbonyls).
• Treatment attenuated cardiac fibrogenesis and inflammation, evidenced by reduced expression of fibrosis and inflammatory markers.
• Sildenafil preserved left ventricular function (cardiac output, ejection fraction, stroke volume) and restored oxidant/antioxidant balance.

Conclusions:

• The PDE5A-cGMP-PKG pathway is a key mediator of cardiac dysfunction after severe burn injury.
• Sildenafil effectively recovers burn-induced cardiac dysfunction, highlighting its therapeutic promise.